Catalent Inc. (NYSE:CTLT) finished Wednesday with a subtraction of -$4.0 to close at $83.15, a downside of -4.59 percent. An average of 1,543,320 shares of common stock have been traded in the last five days. There was a fall of -$8.75 in the past week, and it reached a new high 2 times over the past 12 months. The last 20 days have seen an average of 1,539,305 shares traded, while the 50-day average volume stands at 1,169,190.
CTLT stock has decreased by -18.77% in the last month. The company shares reached their 1-month lowest point of $83.10 on 09/21/22. With the stock rallying to its 52-week high on 01/03/22, shares of the company touched a low of $86.11 and a high of $142.09 in 52 weeks. It has reached a new high 1 time so far this year and lost -35.05% or -$44.88 in price. In spite of this, the price is down -41.48% from the 52-week high.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now.
22 days have passed since Catalent Inc. (CTLT) last reported insider trading activity. Hopson Ricky, who is Pres. Clinical Dev Supply Div, most recently acquired $2,216 shares at $89.59 per share on Aug 31. In this transaction, the insider spent $198,531. SVP, Quality & Reg. Affairs, Gunther Scott, disposed of 1,639 shares at a price of $104.07 on Aug 26. The insider now owns more than $170,571 worth of shares. Prior to that, Pres. Bio Product Delivery Div Riley Michael A. went on to Sale 2,491 shares at $104.07 each on Aug 26. An amount of $259,238 was transacted.
Catalent Inc. (CTLT) has a trailing price-to-earnings (P/E) ratio of 29.42. The stock’s beta is 1.36. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 3.07, the price-to-book (PB) ratio at 3.05.
The quick ratio of Catalent Inc. for the three months ended March 30 was 2.00, and the current ratio was 2.70, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.87 and a total debt to equity ratio of 0.88 for the quarter ending March 30. Its gross profit as reported stood at $1.64 billion compared to revenue of $4.83 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Catalent Inc.’s return on assets was 4.90%.
For the three-month period that ended March 30, Catalent Inc. had $89.0 million in cash and short-term investments compared to $4.17 billion in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of $60.9 million in the quarter, while revenues were shrunk -256.49%. The analyst consensus anticipated Catalent Inc.’s latest quarter earnings to come in at $0.94 per share, but it turned out to be $1.04, a 10.60% surprise. For the quarter, EBITDA amounted to $348.0 million. Shareholders own equity worth $179.9 million.
From a technical analysis perspective, let’s take a brief look at Catalent Inc. (CTLT) price momentum. RSI 9-day as of the close on 21 September was 22.71%, suggesting the stock is oversold, with historical volatility in this time frame at 36.31%.
As of today, CTLT’s price is $87.75 -9.52% or -$8.75 from its 5-day moving average. CTLT is currently trading -18.89% lower than its 20-day SMA and -7.51% lower than its 100-day SMA. However, the stock’s current price level is -20.51% below the SMA50 and -32.11% below the SMA200.
The stochastic %K and %D were 12.39% and 19.54%, respectively, and the average true range (ATR) was 3.21. With the 14-day stochastic at 0.35% and the average true range at 3.24, the RSI (14) stands at 27.36%. The stock has reached -3.98 on the 9-day MACD Oscillator while the 14-day reading was at -3.80.
Barclays launched coverage on Catalent Inc. (NYSE: CTLT) in its analyst report released on December 16, 2021. The firm assigned the stock an Overweight rating. The consensus rating for Catalent Inc. (CTLT) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell CTLT, while 2 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 3 analysts, while 10 others rate it as a “buy”.
What is CTLT’s price target for the next 12 months?
Analysts predict a range of price targets between $105.00 and $145.00, with a median target of $125.00. Taking a look at these predictions, the average price target given by analysts for Catalent Inc. (CTLT) stock is $123.75.